NovoCure Ltd

NVCR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0002007766-26-000003
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026

Summary

Type

Sell

Net shares

-1,100

% of shares

-1.06%

Amount (USD)

$14,635

Insider confidence score

46.3 out of 100

Positive

  • Tax withholding obligation
  • Small sell amount (<$50K)

Negative

  • Large tax withholding sell (≥1% of shares)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Sell

Date

2026-03-04

Code

S

Net shares

-1,100.0

Price per Share

$13.31

Amount (USD)

$14,635.94

Acquired/Disposed

Disposed

Shares Owned Before

104,079.0

Shares Owned After

102,979.0

Filing's footnotes

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a &quot;sell to cover&quot; transaction and does not represent a discretionary trade by the reporting person.

2. This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.